Innate Pharma (IDDA.STU) Q3 2026 Earnings

17SepConfirmed
Q1 2026
-0.31
0.03
0.36
0.69

Details

Expected EPS
-0.28694130271625
Actual EPS
N/A
Surprise EPS
0.29
Surprise Percent
+100%

Description

Innate Pharma (IDDA.STU) will report earnings of for Q3 2026 on September 17, 2026.

0 Comments

Share your thoughts